Clinical Trials Browser

Interventional × Curcumin × 30 days × Clear all

NCT06626230 2026-05-18

Safety of Anal Curcumin

Phase 1 Recruiting

Neoplasms

NCT04731844 2026-05-12

Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer

Phase 2 Completed

30 enrolled 13 charts

GenitourinaryPlasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Prostatic Neoplasms